Loading…
Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity
Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD -dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the...
Saved in:
Published in: | Journal of virology 2024-03, Vol.98 (3), p.e0008824 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3 |
container_end_page | |
container_issue | 3 |
container_start_page | e0008824 |
container_title | Journal of virology |
container_volume | 98 |
creator | Yu, Shuang-Shuang Tang, Rong-Chun Zhang, Ao Geng, Shijin Yu, Hengxiang Zhang, Yan Sun, Xiu-Yuan Zhang, Jun |
description | Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD
-dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of
promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705).
primary peritoneal macrophages and
mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies. |
doi_str_mv | 10.1128/jvi.00088-24 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10949466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2968924005</sourcerecordid><originalsourceid>FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3</originalsourceid><addsrcrecordid>eNp1kctP3DAQxi1EBcvjxrnyEaQG_LZzQghKuxIqB0DiZs06ztarxFliZ6X97xvYBcGhp9HM_PTN40PohJJzSpm5WKzCOSHEmIKJHTShpDSFlFTsogkhjBWSm-d9dJDSghAqhBJ7aJ8bbpQ2dIKqGw_O53UDyeOH0OchRExxG3KYQ_YJ5_XS4yme3v4pMMRqm28KIVaD8xVOYR6hCXH-RkDMYRV6aHBo2yGGvD5C32pokj_exkP0dPvz8fp3cXf_a3p9dVcA5yYXToJjzjiuda31DBxI5YmUQknlCFFG69I4qsVYEZ5BSStdz2oualMZV9f8EF1udJfDrPWV8zGPa9hlH1ro17aDYL92Yvhr593Kjk8TpVBqVDjdKvTdy-BTtm1IzjcNRN8NybJSmZIJQuSI_tigru9S6n39MYcS--qMHZ2xb85YJkb8bINDaplddEM_viz9j_3--Y4P4Xfb-D87upeS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2968924005</pqid></control><display><type>article</type><title>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</title><source>Open Access: PubMed Central</source><source>American Society for Microbiology Journals</source><creator>Yu, Shuang-Shuang ; Tang, Rong-Chun ; Zhang, Ao ; Geng, Shijin ; Yu, Hengxiang ; Zhang, Yan ; Sun, Xiu-Yuan ; Zhang, Jun</creator><contributor>Ou, J.-H. James</contributor><creatorcontrib>Yu, Shuang-Shuang ; Tang, Rong-Chun ; Zhang, Ao ; Geng, Shijin ; Yu, Hengxiang ; Zhang, Yan ; Sun, Xiu-Yuan ; Zhang, Jun ; Ou, J.-H. James</creatorcontrib><description>Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD
-dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of
promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705).
primary peritoneal macrophages and
mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies.</description><identifier>ISSN: 0022-538X</identifier><identifier>ISSN: 1098-5514</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/jvi.00088-24</identifier><identifier>PMID: 38386781</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Immunity, Innate ; Immunology ; Interferon Type I - metabolism ; Interferon-gamma ; Mice ; Phosphorylation ; Signal Transduction ; Sirtuin 1 - genetics ; Sirtuin 1 - metabolism ; STAT1 Transcription Factor - metabolism ; Virus Diseases - immunology ; Virus-Cell Interactions</subject><ispartof>Journal of virology, 2024-03, Vol.98 (3), p.e0008824</ispartof><rights>Copyright © 2024 American Society for Microbiology.</rights><rights>Copyright © 2024 American Society for Microbiology. 2024 American Society for Microbiology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3</cites><orcidid>0000-0001-5147-6963 ; 0009-0006-8482-8738</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/jvi.00088-24$$EPDF$$P50$$Gasm2$$H</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/jvi.00088-24$$EHTML$$P50$$Gasm2$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3186,27923,27924,52750,52751,52752,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38386781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ou, J.-H. James</contributor><creatorcontrib>Yu, Shuang-Shuang</creatorcontrib><creatorcontrib>Tang, Rong-Chun</creatorcontrib><creatorcontrib>Zhang, Ao</creatorcontrib><creatorcontrib>Geng, Shijin</creatorcontrib><creatorcontrib>Yu, Hengxiang</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Sun, Xiu-Yuan</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><title>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</title><title>Journal of virology</title><addtitle>J Virol</addtitle><addtitle>J Virol</addtitle><description>Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD
-dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of
promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705).
primary peritoneal macrophages and
mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies.</description><subject>Animals</subject><subject>Immunity, Innate</subject><subject>Immunology</subject><subject>Interferon Type I - metabolism</subject><subject>Interferon-gamma</subject><subject>Mice</subject><subject>Phosphorylation</subject><subject>Signal Transduction</subject><subject>Sirtuin 1 - genetics</subject><subject>Sirtuin 1 - metabolism</subject><subject>STAT1 Transcription Factor - metabolism</subject><subject>Virus Diseases - immunology</subject><subject>Virus-Cell Interactions</subject><issn>0022-538X</issn><issn>1098-5514</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kctP3DAQxi1EBcvjxrnyEaQG_LZzQghKuxIqB0DiZs06ztarxFliZ6X97xvYBcGhp9HM_PTN40PohJJzSpm5WKzCOSHEmIKJHTShpDSFlFTsogkhjBWSm-d9dJDSghAqhBJ7aJ8bbpQ2dIKqGw_O53UDyeOH0OchRExxG3KYQ_YJ5_XS4yme3v4pMMRqm28KIVaD8xVOYR6hCXH-RkDMYRV6aHBo2yGGvD5C32pokj_exkP0dPvz8fp3cXf_a3p9dVcA5yYXToJjzjiuda31DBxI5YmUQknlCFFG69I4qsVYEZ5BSStdz2oualMZV9f8EF1udJfDrPWV8zGPa9hlH1ro17aDYL92Yvhr593Kjk8TpVBqVDjdKvTdy-BTtm1IzjcNRN8NybJSmZIJQuSI_tigru9S6n39MYcS--qMHZ2xb85YJkb8bINDaplddEM_viz9j_3--Y4P4Xfb-D87upeS</recordid><startdate>20240319</startdate><enddate>20240319</enddate><creator>Yu, Shuang-Shuang</creator><creator>Tang, Rong-Chun</creator><creator>Zhang, Ao</creator><creator>Geng, Shijin</creator><creator>Yu, Hengxiang</creator><creator>Zhang, Yan</creator><creator>Sun, Xiu-Yuan</creator><creator>Zhang, Jun</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5147-6963</orcidid><orcidid>https://orcid.org/0009-0006-8482-8738</orcidid></search><sort><creationdate>20240319</creationdate><title>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</title><author>Yu, Shuang-Shuang ; Tang, Rong-Chun ; Zhang, Ao ; Geng, Shijin ; Yu, Hengxiang ; Zhang, Yan ; Sun, Xiu-Yuan ; Zhang, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Immunity, Innate</topic><topic>Immunology</topic><topic>Interferon Type I - metabolism</topic><topic>Interferon-gamma</topic><topic>Mice</topic><topic>Phosphorylation</topic><topic>Signal Transduction</topic><topic>Sirtuin 1 - genetics</topic><topic>Sirtuin 1 - metabolism</topic><topic>STAT1 Transcription Factor - metabolism</topic><topic>Virus Diseases - immunology</topic><topic>Virus-Cell Interactions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Shuang-Shuang</creatorcontrib><creatorcontrib>Tang, Rong-Chun</creatorcontrib><creatorcontrib>Zhang, Ao</creatorcontrib><creatorcontrib>Geng, Shijin</creatorcontrib><creatorcontrib>Yu, Hengxiang</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Sun, Xiu-Yuan</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Shuang-Shuang</au><au>Tang, Rong-Chun</au><au>Zhang, Ao</au><au>Geng, Shijin</au><au>Yu, Hengxiang</au><au>Zhang, Yan</au><au>Sun, Xiu-Yuan</au><au>Zhang, Jun</au><au>Ou, J.-H. James</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity</atitle><jtitle>Journal of virology</jtitle><stitle>J Virol</stitle><addtitle>J Virol</addtitle><date>2024-03-19</date><risdate>2024</risdate><volume>98</volume><issue>3</issue><spage>e0008824</spage><pages>e0008824-</pages><issn>0022-538X</issn><issn>1098-5514</issn><eissn>1098-5514</eissn><abstract>Type I and type II IFNs are important immune modulators in both innate and adaptive immunity. They transmit signaling by activating JAK-STAT pathways. Sirtuin 1 (SIRT1), a class III NAD
-dependent deacetylase, has multiple functions in a variety of physiological processes. Here, we characterized the novel functions of SIRT1 in the regulation of type I and type II IFN-induced signaling. Overexpression of SIRT1 inhibited type I and type II IFN-induced interferon-stimulated response element activation. In contrast, knockout of
promoted type I and type II IFN-induced expression of ISGs and inhibited viral replication. Treatment with SIRT1 inhibitor EX527 had similar positive effects. SIRT1 physically associated with STAT1 or STAT3, and this interaction was enhanced by IFN stimulation or viral infection. By deacetylating STAT1 at K673 and STAT3 at K679/K685/K707/K709, SIRT1 downregulated the phosphorylation of STAT1 (Y701) and STAT3 (Y705).
primary peritoneal macrophages and
mice exhibited enhanced IFN-induced signaling and antiviral activity. Thus, SIRT1 is a novel negative regulator of type I and type II IFN-induced signaling through its deacetylase activity.IMPORTANCESIRT1 has been reported in the precise regulation of antiviral (RNA and DNA) immunity. However, its functions in type I and type II IFN-induced signaling are still unclear. In this study, we deciphered the important functions of SIRT1 in both type I and type II IFN-induced JAK-STAT signaling and explored the potential acting mechanisms. It is helpful for understanding the regulatory roles of SIRT1 at different levels of IFN signaling. It also consolidates the notion that SIRT1 is an important target for intervention in viral infection, inflammatory diseases, or even interferon-related therapies.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>38386781</pmid><doi>10.1128/jvi.00088-24</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0001-5147-6963</orcidid><orcidid>https://orcid.org/0009-0006-8482-8738</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-538X |
ispartof | Journal of virology, 2024-03, Vol.98 (3), p.e0008824 |
issn | 0022-538X 1098-5514 1098-5514 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10949466 |
source | Open Access: PubMed Central; American Society for Microbiology Journals |
subjects | Animals Immunity, Innate Immunology Interferon Type I - metabolism Interferon-gamma Mice Phosphorylation Signal Transduction Sirtuin 1 - genetics Sirtuin 1 - metabolism STAT1 Transcription Factor - metabolism Virus Diseases - immunology Virus-Cell Interactions |
title | Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T07%3A34%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deacetylase%20Sirtuin%201%20mitigates%20type%20I%20IFN-%20and%20type%20II%20IFN-induced%20signaling%20and%20antiviral%20immunity&rft.jtitle=Journal%20of%20virology&rft.au=Yu,%20Shuang-Shuang&rft.date=2024-03-19&rft.volume=98&rft.issue=3&rft.spage=e0008824&rft.pages=e0008824-&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/jvi.00088-24&rft_dat=%3Cproquest_pubme%3E2968924005%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a338t-c5ac2c8c377f77baca56e0554656c00687798c1745464e2a91d7fbf34f8d8cff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2968924005&rft_id=info:pmid/38386781&rfr_iscdi=true |